Bicalutamide (Casodex®) in the treatment of prostate cancer
@article{Fradet2004BicalutamideI, title={Bicalutamide (Casodex®) in the treatment of prostate cancer}, author={Y. Fradet}, journal={Expert Review of Anticancer Therapy}, year={2004}, volume={4}, pages={37 - 48} }
Prostate cancer is an important healthcare issue in men worldwide. With the advent of prostate-specific antigen screening and improved diagnostic techniques, prostate cancer is now being diagnosed in younger men and at earlier disease stages. As a result, patients often live with their disease for many years after diagnosis. This shift in the patient profile has focused attention to the impact of treatment on quality of life. Medical/surgical castration has traditionally been the mainstay of… Expand
Topics from this paper
70 Citations
Striving Toward a Cure for Prostate Cancer.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2016
- 5
- PDF
Bicalutamide-induced hepatotoxicity: A rare adverse effect
- Medicine
- The American journal of case reports
- 2014
- 13
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities
- Medicine
- International braz j urol : official journal of the Brazilian Society of Urology
- 2021
- 2
- PDF
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.
- Medicine
- The Lancet. Oncology
- 2016
- 141
- PDF
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
- Chemistry, Medicine
- Proceedings of the National Academy of Sciences of the United States of America
- 2005
- 319
- PDF
Development of a Benzopyran‐Containing Androgen Receptor Antagonist to Treat Antiandrogen‐Resistant Prostate Cancer
- Medicine
- ChemMedChem
- 2010
- 19
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 2017
- 20
Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
- Medicine
- Endocrine journal
- 2012
- 14
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
- Biology, Medicine
- Molecular Cancer
- 2011
- 31
Nonsurgical management of hyperadrenocorticism in ferrets.
- Medicine
- The veterinary clinics of North America. Exotic animal practice
- 2014
- 5
References
SHOWING 1-10 OF 96 REFERENCES
Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function
- Medicine
- BJU international
- 2001
- 68
Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer
- Medicine
- Clinical pharmacokinetics
- 1998
- 72
A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer.
- Medicine
- Urology
- 1996
- 90
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1997
- 173
Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
- Medicine
- The Journal of urology
- 1998
- 12
Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?
- Medicine
- Prostate Cancer and Prostatic Diseases
- 2001
- 44
- PDF
Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program
- Medicine
- Oncology
- 2003
- 7
- PDF
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1999
- 139
High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy.
- Medicine
- The Journal of urology
- 1998
- 215